Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OncoDiag
company
About
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €2.50M
- Industries
- Biotechnology,Health Care
- Founded date
- May 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€3.10M
OncoDiag has raised a total of
€3.10M
in funding over 2 rounds. Their latest funding was raised on
Mar 15, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2021 | Series A | €2.50M | 3 | — | — | Detail |
| Dec 20, 2018 | Angel | €600K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
OncoDiag is funded by 3 investors.
SFINE
and Normandie Business Angels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SFINE
|
— | Series A |
Normandie Business Angels
|
— | Series A |
Business Angels des Grandes Ecoles
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
